Overexpression of both MET and EGFR is commonly found in the same malignant tumor, such as CRC.282 Compensatory activity regains of MET or EGFR after targeted treatment of either of them has been observed in various studies, strongly implying the existence of crosstalk between MET and EGFR. Here, MET is linked to cancer.